REGENERON PHARMACEUTICALS INC 4
4 · REGENERON PHARMACEUTICALS INC · Filed Jan 5, 2017
Insider Transaction Report
Form 4
BAKER CHARLES A
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2017-01-03+7,830→ 7,830 totalExercise: $376.69Exp: 2027-01-03→ Common Stock (7,830 underlying)
Footnotes (1)
- [F1]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.